PIM2 and mature T-cell and NK-cell non-Hodgkin lymphoma: A large fraction of the PTCL patients showed increased PIM2 protein expression, regardless of their subtype (although with a slight predominance in AITL, where a PIM2 increased expression has been already reported [38]).